From: Bryan Burns [burnsb@astro.temple.edu] Sent: Tuesday, February 13, 2001 1:48 PM To: fdadockets@oc.fda.gov Subject: re: dockets . 00N-1396 and 00D-1598 Dear Commissioner Henney, I am taking the opportunity to write you during the open comments period to express my dismay that the proposed regulations regarding Genetically Modified Foods do not require that such products be clearly labelled. I have concerns about how this can affect people on strict diets, for health or religious reasons, as well as simply the public's assumed right-to-know about what they choose to put into their bodies. None of the above parties are well served by a continued lack of pertinent information. Naturally, large agribusiness and grocery concerns are reticent to see labelling that they fear will cut into their profits or marketability. Likely those same groups were also resistant to nutritional labelling on foods as well. Yet the overall impact of nutritional information has been positive without crippling these industries. People continue to buy potato chips and Big Macs in large numbers despite the prominently placed information about fat grams, sodium, sugar, and calories. But for those who have a need to be aware of such items, this labelling has proven invaluable by giving them better knowledge to make informed decisions that best suit their own health and lifestyle requirements. Surely this would be the case with GM foods as well. Individuals who choose price and convenience will continue to dominate the marketplace for years to come. One need only look at the growing but still tiny organic produce market for confirmation of that. I believe that the first priority of a government organization such as FDA is to inform and protect citizens. That reason alone should be sufficient to warrant mandatory labelling. However, I believe the case can also be strongly made that those agricultural products not containing GM foods are being put at a distinct disadvantage on the world market as other developed nations strengthen their labelling requirements. Our share will continue to decline in first-world countries without such labelling. Lastly, I think that FDA should take a proactive position with regard to the type and content of labelling. Many industry professionals believe that consumer demand will eventually force companies to self-label, as was the case with 'dolphin-free' tuna. As one would expect, industry would likely want something incredibly benign while consumer and environmental advocates would prefer something akin to the skull-and-crossbones. FDA has an opportunity and an obligation to set the standard for a label that provides full disclosure without being threatening. Thank you for your time and consideration. Best regards, Bryan P. Burns 326 West Durham Street Philadelphia, PA 19119